INS and obesity due to melanocortin 4 receptor deficiency: This integrative strategy targets both the physiological and behavioral determinants of weight regulation, resulting in significant reductions in BMI and fat mass, as well as improvements in cardiovascular profiles, insulin sensitivity, and other obesity-related comorbidities.